Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses

Archive ouverte

Macho-Fernandez, Elodie | Chekkat, Neila | Ehret, Christophe | Thomann, Jean-Sébastien | de Giorgi, Marcella | Spanedda, Maria Vittoria | Bourel-Bonnet, Line | Betbeder, Didier | Heurtault, Béatrice | Faveeuw, Christelle | Fournel, Sylvie | Frisch, Benoit | Trottein, François

Edité par CCSD ; Elsevier -

International audience. The potent antitumor effect of α-galactosylceramide (α-GalCer) is based on its recognition by invariant Natural Killer T cells (iNKT) after its capture and presentation by antigen presenting cells including dendritic cells (DCs). Synthetic α-GalCer has already been tested in advanced cancer patients but no or only moderate clinical responses were obtained.To optimize α-GalCer efficacy, we have postulated that alternative formulations impacting its molecular organization in aqueous medium could modify DC uptake and iNKT-based immune responses. To this end, we have developed two strategies: (1) the formulation of α-GalCer in non-cationic liposomes and (2) the synthesis of a water-soluble α-GalCer analogue by anchoring a polyethyleneglycol moiety on its sugar head. The biological activities of these new preparations were compared to that induced by the classically used Polysorbate 20 α-GalCer micelles. Both formulations retained their uptake by DCs and activated iNKT cells both in vitro and in vivo. Despite a lower cytokine production, the formulations induced a potent immune response able to control lung murine carcinoma. In conclusion, it is possible to increase α-GalCer solubility in aqueous solution without limiting its antitumor properties.

Consulter en ligne

Suggestions

Du même auteur

Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.

Archive ouverte | Macho Fernandez, Elodie | CCSD

International audience. Invariant Natural Killer T (iNKT) cells have potent immunostimulatory activities that could be exploited for human therapies. The high-affinity CD1d antigen α-galactosylceramide analogue KRN7...

Synthetic ligands of death receptor 5 display a cell-selective agonistic effect at different oligomerization levels

Archive ouverte | Beyrath, Julien | CCSD

International audience. DR4 (Death Receptor 4) and DR5 (Death Receptor 5) are two potential targets for cancer therapy due to their ability to trigger apoptosis of cancer cells, but not normal ones, when activated b...

Smart tools and orthogonal click-like reactions onto small unilamellar vesicles

Archive ouverte | Salomé, Christophe | CCSD

International audience

Chargement des enrichissements...